| P50 | author | Steven M Handler | Q51448076 |
| P2093 | author name string | Joseph T Hanlon | |
| | Nicholas G Castle | |
| P2860 | cites work | Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group | Q28371928 |
| | Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. | Q33203719 |
| | Influence of facility characteristics on use of antipsychotic medications in nursing homes | Q34143919 |
| | Does an increase in the Medicaid reimbursement rate improve nursing home quality? | Q34178945 |
| | Consensus development conference on antipsychotic drugs and obesity and diabetes | Q34293049 |
| | Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial. | Q34497247 |
| | Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. | Q34573456 |
| | Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials | Q34651137 |
| | Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes | Q36055414 |
| | Nursing home profit status and quality of care: is there any evidence of an association? | Q36063051 |
| | The quality of antipsychotic drug prescribing in nursing homes | Q36163125 |
| | Analysis of repeated categorical data using generalized estimating equations | Q36740752 |
| | Exposure to antipsychotics and risk of stroke: self controlled case series study | Q36854680 |
| | Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions | Q37231448 |
| | Risk-adjusted outcome measures and quality of care in nursing homes | Q38558559 |
| | The association of Nursing Home Compare quality measures with market competition and occupancy rates | Q40102821 |
| | Effect of the Omnibus Reconciliation Act 1987 on antipsychotic prescribing in nursing home residents | Q40623224 |
| | Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations | Q40802281 |
| | Restraining restraints: changes in a standard of care | Q40821868 |
| | Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents | Q44947962 |
| | Antipsychotic drug use among elderly nursing home residents in the United States. | Q46083783 |
| | Atypical antipsychotic medications and risk of falls in residents of aged care facilities | Q46633386 |
| | Nursing home staffing and its relationship to deficiencies | Q46712972 |
| | The use of atypical antipsychotics in nursing homes | Q47374388 |
| | Guided prescription of psychotropic medications for geriatric inpatients. | Q51931250 |
| | A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. | Q51981345 |
| | The relationship between quality of care and financial performance in nursing homes. | Q52020717 |
| | Variation in Nursing Home Antipsychotic Prescribing Rates | Q58070500 |
| | The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes | Q68051207 |
| | Differences in nursing homes with increasing and decreasing use of physical restraints | Q73458352 |
| | Nursing home closures, changes in ownership, and competition | Q81628764 |
| P433 | issue | 3 | |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 143-150 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | American Journal of Geriatric Pharmacotherapy | Q15764532 |
| P1476 | title | Results of a longitudinal analysis of national data to examine relationships between organizational and market characteristics and changes in antipsychotic prescribing in US nursing homes from 1996 through 2006. | |
| P478 | volume | 7 | |